日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Cell membranes-encapsulated gadolinium-doped carbon dots for the efficient photothermal and immunotherapeutic synergistic treatment of hepatocellular carcinoma

细胞膜包裹的钆掺杂碳点用于高效光热和免疫治疗协同治疗肝细胞癌

期刊:Journal of Nanobiotechnology
影响因子:12.6
doi:10.1186/s12951-026-04123-9
Dong, Wenhui; Wei, Yingying; Cao, Chenyue; Mu, Hongkai; Zhou, Shizhao; Xiao, Yueyong; Yang, Yongzhen; Chen, Lin; Yu, Shiping
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Metal-organic framework nanoparticles induced non-apoptotic cell death: Construction, mechanisms, and cancer therapy

金属有机框架纳米颗粒诱导非凋亡性细胞死亡：构建、机制及癌症治疗

期刊:Materials Today Bio
影响因子:10.2
doi:10.1016/j.mtbio.2026.103111
Ma, Shaoshi; Wei, Yingying; Li, Yajie; Dong, Wenhui; Mu, Hongkai; Zhou, Shizhao; Zhang, Xiao; Chen, Lin; Yang, Yongzhen; Yu, Shiping
凋亡
细胞生物学
表观遗传
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Nanocomposites to Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Therapy

纳米复合材料克服肝细胞癌治疗中的索拉非尼耐药性

期刊:International Journal of Nanomedicine
影响因子:6.5
doi:10.2147/IJN.S535455
Liu, Jie; Zhou, Shizhao; Wei, Yingying; Du, Jinglei; Jia, Fan; Dong, Wenhui; Cao, Yangyi; Shi, Zhenyang; Mu, Hongkai; Chen, Lin; Yu, Shiping
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Construction of Cationic Carbon Dots Carrying Survivin siRNA Delivery System and Its Active Targeting Therapy for Liver Cancer.

构建携带 Survivin siRNA 递送系统的阳离子碳点及其在肝癌中的主动靶向治疗

期刊:International Journal of Nanomedicine
影响因子:6.5
doi:10.2147/IJN.S521972
Xue Wenqiang, Du Jinglei, Wei Yingying, Zhou Shizhao, Wang Shicai, Yang Yongzhen, Chen Lin, Yu Shiping
肿瘤
肝癌
发表日期：2025
文献求助 收藏

Ghrelin's potential as a therapeutic target for chronic inflammatory diseases: evidence from human endometrial stromal cells

生长素释放肽作为慢性炎症疾病治疗靶点的潜力：来自人子宫内膜间质细胞的证据

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1587490
Dong, Wenhui; Mu, Hongkai; Jia, Fan; Wei, Yingying; Lv, JingJing; Zhou, Shizhao; Yu, Shiping; Liang, Tingting
炎症/感染
细胞生物学
炎症
发表日期：2025
文献求助 收藏

Chemotherapy alone versus chemotherapy plus targeted therapy as adjuvant therapy for initially unresectable colorectal cancer liver metastases: a multicenter cohort study

单纯化疗与化疗联合靶向治疗作为初始不可切除结直肠癌肝转移辅助治疗的疗效比较：一项多中心队列研究

期刊:Gastroenterology Report
影响因子:4.2
doi:10.1093/gastro/goaf098
Chang, Wenju; Zhou, Shizhao; Guan, Xu; Xu, Donghao; Liu, Yu; Tang, Wentao; Lv, Yang; Qin, Xiaorui; Liang, Fei; Wang, Xiaoying; Ren, Li; Fan, Jia; Wei, Ye; Wang, Xishan; Xu, Jianmin
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study

解剖性切除术可改善KRAS/NRAS/BRAF突变或右侧结肠癌患者的结直肠肝转移无复发生存期：一项回顾性队列研究

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000000562
Chang, Wenju; Chen, Yijiao; Zhou, Shizhao; Ren, Li; Xu, Yuqiu; Zhu, Dexiang; Tang, Wentao; Ye, Qinghai; Wang, Xiaoying; Fan, Jia; Wei, Ye; Xu, Jianmin
肿瘤
肠癌
肿瘤免疫
BRAF
RAS
发表日期：2023
文献求助 收藏

Robotic versus open surgery for simultaneous resection of rectal cancer and liver metastases: a randomized controlled trial

机器人手术与开放手术同时切除直肠癌和肝转移瘤：一项随机对照试验

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000000581
Chang, Wenju; Ye, Qinghai; Xu, Donghao; Liu, Yu; Zhou, Shizhao; Ren, Li; He, Guodong; Zhou, Guofeng; Liang, Fei; Fan, Jia; Wei, Ye; Wang, Xiaoying; Xu, Jianmin
肿瘤
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: a multicentre cohort study

基于深度放射组学融合模型预测贝伐单抗治疗结直肠癌肝转移患者的疗效和预后：一项多中心队列研究

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.102271
Zhou, Shizhao; Sun, Dazhen; Mao, Wujian; Liu, Yu; Cen, Wei; Ye, Lechi; Liang, Fei; Xu, Jianmin; Shi, Hongcheng; Ji, Yuan; Wang, Lisheng; Chang, Wenju
肿瘤
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏